MicroRNA targeting: A novel therapeutic intervention for ovarian cancer

被引：7

作者：

Asl, Elmira Roshani ^{[1
]}

Sarabandi, Sajed ^{[2
]}

Shademan, Behrouz ^{[3
]}

Dalvandi, Kourosh ^{[4
]}

Sheikhansari, Golshan ^{[5
]}

Nourazarian, Alireza ^{[6
]}

机构：

[1] Saveh Univ Med Sci, Social Determinants Hlth Res Ctr, Saveh, Iran

[2] Islamic Azad Univ Karaj, Fac Med Sci, Dept Vet, Karaj, Iran

[3] Tabriz Univ Med Sci, Stem Cell Res Ctr, Tabriz, Iran

[4] Minist Hlth & Med Educ, Hlth Dept, Tehran, Iran

[5] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran

[6] Khoy Univ Med Sci, Dept Basic Med Sci, Khoy, Iran

来源：

BIOCHEMISTRY AND BIOPHYSICS REPORTS | 2023年 / 35卷

关键词：

Ovarian cancer; microRNA; Prognostics; Biomarker; Diagnostic biomarker; Therapeutic strategy; MESSENGER-RNAS; BREAST-CANCER; HEPATITIS-C; EXPRESSION; BIOMARKER; FAMILY; PROGRESSION; MECHANISMS; DIAGNOSIS; SEQUENCE;

D O I：

10.1016/j.bbrep.2023.101519

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Ovarian cancer, a perilous form of cancer affecting the female reproductive system, exhibits intricate communication networks that contribute to its progression. This study aims to identify crucial molecular abnormalities linked to the disease to enhance diagnostic and therapeutic strategies. In particular, we investigate the role of microRNAs (miRNAs) as diagnostic biomarkers and explore their potential in treating ovarian cancer. By targeting miRNAs, which can influence multiple pathways and genes, substantial therapeutic benefits can be attained. In this review we want to shed light on the promising application of miRNA-based interventions and provide insights into the specific miRNAs implicated in ovarian cancer pathogenesis.

引用

页数：8

共 50 条

[31] MicroRNA Expression Profile in Patients Admitted to ICU as Novel and Reliable Approach for Diagnostic and Therapeutic Purposes
Yan, Youqin
Liao, Linjun
MOLECULAR BIOTECHNOLOGY, 2024, 66 (06) : 1357 - 1375
[32] Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention
Buonaiuto, Roberto
Neola, Giuseppe
Cecere, Sabrina Chiara
Caltavituro, Aldo
Cefaliello, Amedeo
Pietroluongo, Erica
De Placido, Pietro
Giuliano, Mario
Arpino, Grazia
De Angelis, Carmine
BIOMOLECULES, 2023, 13 (04)
[33] microRNA and Ovarian Cancer
Langhe, Ream
MICRORNA: CANCER: FROM MOLECULAR BIOLOGY TO CLINICAL PRACTICE, 2015, 889 : 119 - 151
[34] Enhancing the sensitivity of ovarian cancer cells to olaparib via microRNA-20b-mediated cyclin D1 targeting
Zhong, Qian
Xiong, Ying
Ling, Chen
Qian, Yanping
Zhao, Xia
Yang, Hanshuo
EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (11) : 1297 - 1306
[35] Targeting NaPi2b in ovarian cancer
Banerjee, Susana
Drapkin, Ronny
Richardson, Debra L.
Birrer, Michael
CANCER TREATMENT REVIEWS, 2023, 112
[36] Exosomal microRNA: a novel biomarker for breast cancer
He, Yunjie
Deng, Fei
Yang, Sujin
Wang, Dandan
Chen, Xiu
Zhong, Shanliang
Zhao, Jianhua
Tang, Jinhai
BIOMARKERS IN MEDICINE, 2018, 12 (02) : 177 - 188
[37] Overexpression of microRNA-497 suppresses cell proliferation and induces apoptosis through targeting paired box 2 in human ovarian cancer
Lin, Zhong
Zhao, Junling
Wang, Xindan
Zhu, Xuehong
Gong, Liansheng
ONCOLOGY REPORTS, 2016, 36 (04) : 2101 - 2107
[38] Upregulation of MicroRNA-34a Sensitizes Ovarian Cancer Cells to Resveratrol by Targeting Bcl-2
Yao, Shangli
Gao, Ming
Wang, Zujun
Wang, Wenyan
Zhan, Lei
Wei, Bing
YONSEI MEDICAL JOURNAL, 2021, 62 (08) : 691 - 701
[39] Candidate microRNA biomarkers in human epithelial ovarian cancer: systematic review profiling studies and experimental validation
Chen, Ying
Zhang, Lei
Hao, Quan
CANCER CELL INTERNATIONAL, 2013, 13
[40] MicroRNA-200a inhibits CD133/1+ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2
Wu, Qiuhua
Guo, Rongjiao
Lin, Min
Zhou, Bing
Wang, Yifeng
GYNECOLOGIC ONCOLOGY, 2011, 122 (01) : 149 - 154

← 1 2 3 4 5 →